A wrap-around approach to managing endometriosis

0
With a new medicine available for endometriosis, here's how pharmacists can screen for the ‘missed disease’ and discuss appropriate options.

ATAGI highlights progress amid resurgent diseases

0
ATAGI flagged worrying vaccine coverage declines and renewed disease threats, with pharmacists tipped to boost community protection.

Pharmacists go above and beyond as Victorian storm leads to weeks...

0
Thousands of residents continue to be left without electricity or running water after storms battered Victoria’s Dandenong Ranges recently. AP speaks to pharmacists on the ground.

Aus CVD risk: the Australian cardiovascular disease risk calculator

0
The 2023 Aus CVD Risk calculator and guideline provide updated evidence-based recommendations for identifying, assessing, communicating and managing CVD risk in a primary prevention setting.

How expanded scope is redefining pharmacy practice

0
Rapidly evolving scope of practice means that traditional community pharmacy workflows need review. What works (and what doesn’t)?

Vyvanse® (lisdexamfetamine dimesilate) for treatment of adults with ADHD

0
Vyvanse® (lisdexamfetamine dimesilate) for treatment of adults with ADHD: PBS listed from 1 February 20211,2